Tissue-Engineered Recombinant Human Collagen-Based Corneal Substitutes for Implantation: Performance of Type I versus Type III Collagen
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
PURPOSE: To compare the efficacies of recombinant human collagens types I and III as corneal substitutes for implantation. METHODS: Recombinant human collagen (13.7%) type I or III was thoroughly mixed with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide and N-hydroxysuccinimide. The final homogenous solution was either molded into sheets for in vitro studies or into implants with the appropriate corneal dimensions for transplantation into minipigs. Animals with implants were observed for up to 12 months after surgery. Clinical examinations of the cornea included detailed slit lamp biomicroscopy, in vivo confocal microscopy, and fundus examination. Histopathologic examinations were also performed on corneas harvested after 12 months. RESULTS: Both cross-linked recombinant collagens had refractive indices of 1.35, with optical clarity similar to that in human corneas. Their chemical and mechanical properties were similar, although RHC-III implants showed superior optical clarity. Implants into pig corneas over 12 months show comparably stable integration, with regeneration of corneal cells, tear film, and nerves. Optical clarity was also maintained in both implants, as evidenced by fundus examination. CONCLUSIONS: Both RHC-I and -III implants can be safely and stably integrated into host corneas. The simple cross-linking methodology and recombinant source of materials makes them potentially safe and effective future corneal matrix substitutes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collagen types I, III, and V in human embryonic and fetal skin
Smith, L. T., Holbrook, K. A., & Madri, J. A. (1986) · American Journal of Anatomy · doi:10.1002/aja.1001750409 · Cited by 207
Cited by
Fagerholm, P., Lagali, N. S., Merrett, K., Jackson, W. B., Munger, R., Liu, Y., Polarek, J. W., Söderqvist, M., & Griffith, M. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001022 · Cited by 420
Self-citationGelatin-Based Materials in Ocular Tissue Engineering
Rose, J., Pacelli, S., Haj, A., Dua, H., Hopkinson, A., White, L., & Rose, F. (2014) · Materials · doi:10.3390/ma7043106 · Cited by 327
Design, clinical translation and immunological response of biomaterials in regenerative medicine
Sadtler, K., Singh, A., Wolf, M. T., Wang, X., Pardoll, D. M., & Elisseeff, J. H. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.40 · Cited by 319
Organ-on-a-chip platforms: a convergence of advanced materials, cells, and microscale technologies
Ahadian, S., Civitarese, R., Bannerman, D., Mohammadi, M. H., Lu, R., Wang, E., Davenport‐Huyer, L., Lai, B., Zhang, B., Zhao, Y., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700506 · Cited by 315
Dental Pulp Tissue Engineering in Full-length Human Root Canals
Rosa, V., Zhang, Z., Grande, R. H. M., & Nör, J. E. (2013) · Journal of Dental Research · doi:10.1177/0022034513505772 · Cited by 312
Metadata
- Authors
- Merrett, K., Fagerholm, P., McLaughlin, C. R., Dravida, S., Lagali, N., Shinozaki, N., Watsky, M. A., Munger, R., Kato, Y., Li, F., Marmo, C. J., & Griffith, M.
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2008-09-01
- Volume
- 49
- Issue
- 9
- Pages
- 3887
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2025339018
- Cited by
- 146
- References
- 1
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tissue-Engineered Recombinant Human Collagen-Based Corneal Substitutes for Implantation: Performance of Type I versus Type III Collagen. https://app.cochat.ai/papers/10.1167/iovs.07-1348
- The paper
- Merrett, K., Fagerholm, P., McLaughlin, C. R., Dravida, S., Lagali, N., Shinozaki, N., Watsky, M. A., Munger, R., Kato, Y., Li, F., Marmo, C. J., & Griffith, M. (2008). Tissue-Engineered Recombinant Human Collagen-Based Corneal Substitutes for Implantation: Performance of Type I versus Type III Collagen. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.07-1348
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.